Funding sources: this study was funded by the Ministero dell’Istruzione, dell’Università e della Ricerca, Fondo per gli Investimenti della Ricerca di Base 2009–2011 and Regione Lombardia (Network-Enabled Drug Design) 2011.
Compound heterozygosity of the novel −186C>T mutation in the COL7A1 promoter and the recurrent c.497insA mutation leads to generalized dystrophic epidermolysis bullosa
Article first published online: 31 JAN 2013
© 2012 The Authors. BJD © 2012 British Association of Dermatologists
British Journal of Dermatology
Volume 168, Issue 4, pages 904–906, April 2013
How to Cite
Ritelli, M., Chiarelli, N., Quinzani, S., Dordoni, C., Venturini, M., Calzavara-Pinton, P. and Colombi, M. (2013), Compound heterozygosity of the novel −186C>T mutation in the COL7A1 promoter and the recurrent c.497insA mutation leads to generalized dystrophic epidermolysis bullosa. British Journal of Dermatology, 168: 904–906. doi: 10.1111/bjd.12063
Conflicts of interest: none declared.
- Issue published online: 25 MAR 2013
- Article first published online: 31 JAN 2013
- Accepted manuscript online: 26 SEP 2012 12:20PM EST
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.